Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 620 participants.

Also called NCT01735227

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 620 participants (planned count) (from the registry)
Sponsor
Yaling Han (from the registry)
Registry
  • NCT NCT01735227
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01735227. Randomized; single masking; primary purpose prevention. Start 2012-11 (registry gives no type); primary completion 2013-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)
Condition
Acute Coronary Syndromes
Intervention (Drug)
omeprazole
Intervention (Drug)
Pantoprazole
Lead sponsor
Yaling Han (class: other)

Record details

Record id
cardio:ct-nct01735227
Content hash
ecc93939a01635e13ac82863c2f69d95ba092f0c70b88f8816311580efdc092f